Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2011 Jan:31 Suppl 3:321-3.
doi: 10.1007/s10072-010-0351-0.

Natalizumab efficacy on cognitive impairment in MS

F Mattioli  1 , C Stampatori, F Bellomi, R Capra
Affiliations
Comparative Study

Natalizumab efficacy on cognitive impairment in MS

F Mattioli et al. Neurol Sci. 2011 Jan.

Abstract

We report follow-up data on the efficacy of natalizumab therapy on neuropsychological impairment on an italian MS group of 39 patients at 1 year and of 11 patients at 2 years. Results show a significant reduction in relapse rate, in the number of impaired neuropsychological tests as well as in several single executive function and reasoning tests scores at 1 year. Improvement persisted at 2 years, including also memory and speed processing tasks. These data support the efficacy of natalizumab therapy in all the clinical domains, including cognitive deterioration, in multiple sclerosis patients.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Mult Scler. 2009 Jan;15(1):2-8 - PubMed
    1. Lancet Neurol. 2009 Mar;8(3):254-60 - PubMed
    1. Lancet Neurol. 2008 Dec;7(12):1139-51 - PubMed
    1. Ital J Neurol Sci. 1987 Dec;Suppl 8:1-120 - PubMed
    1. N Engl J Med. 2006 Mar 2;354(9):899-910 - PubMed

Publication types

Substances

LinkOut - more resources